Ipca Laboratories Ltd.

IPCALAB

₹1313.0

0.27% (3.5)

Market Cap

₹33,281 Cr.

P/E

42.74

Key Ratios

Edit Ratio's

Market cap

33,281 Cr

42.74

Prom Holding

44.72 %

ROE (%)

10.62

ROCE (%)

15.22

Div Yield (%)

0.30

Sales

9,155 Cr

OPM (%)

19.11 %

Debt to Equity

0.19

Edit Ratio's

About

Established in 1949, IPCA Laboratories Limited is an integrated pharmaceutical company that ma… Read more

Low

1200

52W Range

High

1758

Timeline

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statement

New

Edit rows

Forensics

9 Yes

Positive for this company

2 Neutral

Neutral for this company

6 No

Negative for this company

0 No Data

Insufficient data to analyse

Accounting & Shareholding

Contingent Liabilities

Company does not have significant contingent liabilities
Depreciation Effect

Depreciation accounting is not leading to increase in profits
Other Income

Other income is not affecting ratios of the company
Pledge

Promoters have not pledged a significant portion of their holding
Retail Holding

Retail has been selling the stock which is usually a good time to buy
Promoter Holding

Promoters has been selling shares in the open market over last 90 days
Revenue Recognition

Chances of aggressive revenue recognition - operating profit of company is not getting converted to cash and recievables rising faster than sales

Price & Performance

ROE

Asset turnover is responsible for roe increase over last 10 years
Share price

Share price has increased over last 10 years due to earnings
Debt

Company should not have issues servicing its debt
Sales Growth

Sales of the company has grown at a good pace
Capex vs ROCE

Company has made significant capex which might be affecting its roce
Balance Sheet Strength

Balance sheet of the company is strong. but it might have issues paying it suppliers
Current vs Historic Valuation

Company is trading at a premium to 3yr historic valuations
Working Capital

Company has significant working capital which is dragging its roce and roe
Margin Stability

Margins of the company are volatile
ROCE Strength

Roce of the company is not consistently strong

Market Share

0.81 %

(as of Jul 22)

Historic

Anti - Diabetes - Market Share

1.03 %

(as of Jul 22)

Historic

Anti-Infectives - Market Share

55.08 %

(as of Nov 21)

Historic

Anti-Malarial - Market Share

3.84 %

(as of Nov 21)

Historic

Antineo Plastic - Market Share

0.11 %

(as of Nov 21)

Historic

Blood Related - Market Share

2.09 %

(as of Jul 22)

Historic

Cardiovascular - Market Share

1.20 %

(as of Nov 21)

Historic

Dermatology - Market Share

0.12 %

(as of Nov 21)

Historic

Endocrinology - Market Share

1.02 %

(as of Jul 22)

Historic

Gastro-Intestinal - Market Share

1.11 %

(as of Nov 21)

Historic

Neurological - Market Share

0.55 %

(as of Nov 21)

Historic

Ophthalmology - Market Share

8.06 %

(as of Nov 21)

Historic

Pain - Market Share

1.80 %

(as of Dec 22)

Historic

Pharmaceutical Sector - Market Share

0.83 %

(as of Nov 21)

Historic

Respiratory - Market Share

0.39 %

(as of Jul 22)

Historic

Sex Stimulants - Market Share

2.23 %

(as of Nov 21)

Historic

Urology - Market Share

0.43 %

(as of Jul 22)

Historic

Vitamin & Dietary Supplements - Market Share

Revenue mix

Product Wise Break-Up

Therapeutic Area Wise Break-Up - Domestic

Location Wise Break-Up - Branded Generics

Location Wise Break-Up - Generics

Location Wise Break-Up - API

Location Wise Break-Up

Therapeutic Area Break-Up

Operational Metrics

Number of ANDA's Filed in USA (.)
Source
Number of ANDA's Approved By USFDA (.)
Source
Domestic Sales Growth - YoY (%)
Source
US DMF Filings (.)
Source
R&D as a % of Total Sales (%)
Source

Peer Comparison

Corporate Actions

Consolidated

DATE

DETAILS

Show Less

Suppliers

Bharat Dynamics Ltd.
Elgi Equipments Ltd.
Borosil Renewables Ltd.
GMM Pfaudler Ltd.
Gulshan Polyols Ltd.
Iris Business Services Ltd.
TPL Plastech Ltd.
Take Solutions Ltd.

Showing 5 of 8

FAQs on Ipca Laboratories Ltd. Business

What does Ipca Laboratories do?

IPCA Laboratories Limited is a pharmaceutical company founded in 1949, with a global presence in manufacturing and marketing various formulations and APIs across different therapeutic segments. It is a leading supplier of APIs worldwide.

Who are the competitors of Ipca Laboratories?

Ipca Laboratories major competitors are Gland Pharma, Ajanta Pharma, JB Chem & Pharma, Wockhardt, Pfizer, Eris Lifesciences, Astrazeneca Pharma I.
Market Cap of Ipca Laboratories is ₹33,223 Crs.
While the median market cap of its peers are ₹25,164 Crs.

Is Ipca Laboratories financially stable compared to its competitors?

Ipca Laboratories seems to be less financially stable compared to its competitors.
Altman Z score of Ipca Laboratories is 6.42 and is ranked 6 out of its 8 competitors.

View FAQ's On Shareprice

Cash Flow Machines

Actual Cash profits are more important than accounting profits. List of companies spitting out cash profits

Run Query

Monopoly Companies

Companies which are dominant in a product, usually having a strong moat.

Run Query

Global Leaders

Companies with a dominant global position in a product. Might be a sign of very strong moat.

Run Query

Company Filing

	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release	May Aug	Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Dec			Mar	Jun	Sep Dec
Investor Presentation						Mar					Jun Dec	Jun Sep Dec	Dec	Jun Dec
Conference Call	Mar Jun	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Jun Sep Dec	Mar Sep Dec		Sep Dec	Dec		Sep
Conference Call SummaryCon Call Summary Powered by Gemini

Discussions & Analysis

Ipca Laboratories Ltd.

View the discussion on ValuePickr

Pharmaceutical Sector

How The Pharma Industry Works - PPFAS

Deep Dive into Pharma Sector - Omkara Capital

Pharma Compliance In-Depth - Amit Rajan

Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar

Nutraceuticals- Industry Overview - Value Educator

GLP-1: The Drug Redefining Diabetes, Obesity, and Pharma’s Future - Perpetuity

Generic Opportunity for Indian Pharma Companies - Anish Moonka

Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC

Ideas Dashboard

Results

Timeline

Watchlist

Portfolio

Alerts

Stock Screener

Market

Raw Material

Ipca Laboratories Ltd.

Ipca Laboratories Ltd.

Key Ratios

About

Timeline

Company Timeline

Custom financial statement

Forensics

9 Yes

2 Neutral

6 No

0 No Data

Accounting & Shareholding

Contingent Liabilities

Depreciation Effect

Other Income

Pledge

Retail Holding

Promoter Holding

Revenue Recognition

Price & Performance

ROE

Share price

Debt

Sales Growth

Capex vs ROCE

Balance Sheet Strength

Current vs Historic Valuation

Working Capital

Margin Stability

ROCE Strength

Market Share

Revenue mix

Product Wise Break-Up

UNLOCK PREMIUM

Therapeutic Area Wise Break-Up - Domestic

UNLOCK PREMIUM

Location Wise Break-Up - Branded Generics

UNLOCK PREMIUM

Location Wise Break-Up - Generics

UNLOCK PREMIUM

Location Wise Break-Up - API

UNLOCK PREMIUM

Location Wise Break-Up

UNLOCK PREMIUM

Therapeutic Area Break-Up

UNLOCK PREMIUM

Operational Metrics

Peer Comparison

Corporate Actions

Suppliers

FAQs on Ipca Laboratories Ltd. Business

What does Ipca Laboratories do?

Who are the competitors of Ipca Laboratories?

Is Ipca Laboratories financially stable compared to its competitors?

Similar Companies

Company Filing

Discussions & Analysis

SIGN UP FOR FREE